Brandon Griffin joins Advantar Labs

Appointed as vp of sales and marketing

Advantar Labs, a contract provider of GLP and GMP research, formulation development and small-scale clinical packaging services, has added Brandon Griffin to its senior management team as vp of sales and marketing.

The San Diego, California, US-based company has an aggressive expansion plan following triple-digit growth in 2010.

Griffin will head the planning, implementation and management of Advantar’s sales and marketing strategy.

He was previously western regional vp of sales at RohnerChem, a Switzerland-based CMO, heading sales for large-scale custom synthesis of small molecules and novel monomers/biopolymers in the US.

You may also like

Research & Development

Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform

Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic partner in validating its computational platform for adeno-associated virus vector optimisation through laboratory testing
Finance

Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio

The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure
Manufacturing

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production
Manufacturing

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
Research & Development

Phesi analysis finds 6.7% of global clinical trials affected by Middle East disruption

A Phesi analysis of more than 65,000 active clinical trials has found that 4361 studies are impacted by Middle East disruption, with Phase III oncology trials most exposed and all top ten global pharma companies holding significant investigator site presence in affected countries
Packaging

PulPac unveils plastic-like fiber caps

The caps will be presented publicly for the first time at interpack 2026, demonstrating how fiber can move into one of the most widely used and technically demanding components in packaging
Packaging

Smarter weighing for high-dynamic systems

New PW22i IO-Link single-point load cell provides precision, speed and intelligence - embedded at sensor level
Subscribe now